Category
Atomoxetine
CAS Number
105314-53-2
Alternate CAS Number
82857-39-4 (HCL)
Molecular Formula
C₁₇H₂₁NO
Molecular Weight
255.36 g/mol
Synonym

(3S)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;S-(+)-Atomoxetine; (S)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine; (S)-, (+)-Tomoxetine; (S)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropylamine;

Keywords
Pharmaceutical Standards
Intermediates
Fine Chemicals
Impurities Manufacturer in India
Impurities manufacturer and Suppliers in Hyderabad india
Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Atomoxetine EP Impurity B (CAS No. 105314-53-2; HCl Salt CAS No. 82857-39-4), molecular formula C₁₇H₂₁NO and molecular weight 255.36 g/mol, is a chiral Atomoxetine-related impurity and pharmaceutical reference material known as (3S)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine, S-(+)-Atomoxetine, (S)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine, and (S)-(+)-Tomoxetine. Manasa Life Sciences, a leading manufacturer and supplier in India, offers this specialty compound for chiral impurity profiling, API characterization, reference standard testing, stereochemical analysis, chromatographic identification, pharmaceutical process research, analytical method development, quality control, and drug-development studies. Suitable applications include HPLC, chiral HPLC, UHPLC, LC-MS/MS, NMR, FTIR, purity analysis, stability testing, and method validation, with COA, SDS/MSDS, specification sheets, and analytical documentation available for pharmaceutical R&D and laboratory requirements in line with applicable ICH, EMA, USP, EP, and US FDA expectations.